A recent publication suggested that TFEB de-phosphorylation and nuclear translocation in a model of Niemann-Pick type C disease (NPC) upon c-Abl inhibition with dasatinib (Contreras et al., 2020). This evidence concerns the gene TFEB and Niemann-Pick disease type C.